Drospirenone (Compound)

Synonyms:Drospirenone, 67392-87-4, Dihydrospirorenone, Dehydrospirorenone, Drospirenona, 1,2-Dihydrospirorenone, DRSP, Drospirenonum, Drospirenonum [INN-Latin], Drospirenona [INN-Spanish], ZK 30595, Slynd, ZK-30595, DTXSID7046465, CHEBI:50838, N295J34A25, NSC-760103, (6R,7R,8R,9S,10R,13S,14S,15S,16S,17S)-1,3',4',6,6a,7,8,9,10,11,12,13,14,15,15a,16-Hexadecahydro-10,13-dimethylspiro-(17H-dicyclopropa(6,7:15,16)cyclopenta(a)phenanthrene-17,2'(5'H)-furan)-3,5'(2H)-dione, 17-Hydroxy-6beta,7beta:15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21-carboxylic acid, gamma-lactone, Drospirenone [INN], (1R,2R,4R,10R,11S,14S,15S,16S,18S,19S)-10,14-dimethylspiro[hexacyclo[9.8.0.0^{2,4}.0^{5,10}.0^{14,19}.0^{16,18}]nonadecane-15,2'-oxolan]-5-ene-5',7-dione, DTXCID5026465, 6beta,7beta;15beta,16beta-Dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone, CAS-67392-87-4, ZK30595, CCRIS 6523, EINECS 266-679-2, BRN 4765500, UNII-N295J34A25, HSDB 7896, NCGC00164590-01, Drospirenone [USAN:USP:INN:BAN], MFCD00867350, SH-470, Drospirenone- Bio-X, Slynd (TN), 1, 2-Dihydrospirorenone, DROSPIRENONE [MI], DROSPIRENONE [JAN], DROSPIRENONE [USAN], 6-beta,7-beta;15-beta,16-beta-Dimethylene-3-oxo-17-alpha-pregn-4-ene-21,17-carbolactone, CHEMBL1509, DROSPIRENONE [VANDF], DROSPIRENONE [MART.], Spiro(17H-dicyclopropa(6,7:15,16)cyclopenta(a)phenanthrene-17,2'(5'H)-furan)-3,5'(2H)-dione, 1,3',4',6,7,8,9,10,11,12,13,14,15,16,20,21-hexadecahydro-10,13-dimethyl-, (6R-(6alpha,7alpha,8beta,9alpha,10beta,13beta,14alpha,15alpha,16alpha,17beta))-, DROSPIRENONE [USP-RS], DROSPIRENONE [WHO-DD], SCHEMBL153316, Drospirenone (JAN/USP/INN), GTPL2874, YAZ COMPONENT DROSPIRENONE, Drospirenone, >=98% (HPLC), BCPP000250, BDBM150275, DROSPIRENONE [ORANGE BOOK], BEYAZ COMPONENT DROSPIRENONE, DROSPIRENONE [EP MONOGRAPH], BCP27035, Drospirenone for peak identification, EX-A3153, HY-B0111, YASMIN COMPONENT DROSPIRENONE, DROSPIRENONE [USP MONOGRAPH], DROSPIRENONE COMPONENT OF YAZ, Tox21_112216, ANGELIQ COMPONENT DROSPIRENONE, s1377, SAFYRAL COMPONENT DROSPIRENONE, AKOS015895237, DROSPIRENONE COMPONENT OF BEYAZ, Tox21_112216_1, BCP9000628, CCG-268245, CS-1863, DB01395, DROSPIRENONE COMPONENT OF YASMIN, NSC 760103, ZK 3059, 6beta,7beta,15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17 carbolactone, DROSPIRENONE COMPONENT OF ANGELIQ, DROSPIRENONE COMPONENT OF SAFYRAL, NCGC00164590-02, NCGC00164590-04, NEXTSTELLIS COMPONENT DROSPIRENONE, AS-13025, BD166530, US8987239, A, DROSPIRENONE COMPONENT OF NEXTSTELLIS, D4209, D03917, AB01274783-01, AB01274783_02, A846434, AR-270/43507886, EN300-19767634, Q419646, SR-01000942231, Q-101411, SR-01000942231-1, BRD-K04394237-001-06-0, Drospirenone, European Pharmacopoeia (EP) Reference Standard, Drospirenone, United States Pharmacopeia (USP) Reference Standard, Drospirenone for peak identification, European Pharmacopoeia (EP) Reference Standard, (1R,2R,4R,10R,11S,14S,15S,16S,18S,19S)-10,14-dimethylspiro[hexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadec-5-ene-15,5'-oxolane]-2',7-dione, 3-oxo-6alpha,7alpha,15alpha,16alpha-tetrahydro-7'H,16'H-dicyclopropa[6,7;15,16]-17alpha-pregn-4-ene-21,17-carbolactone, 5a,7a-dimethyl-1,1a,3,3',4,4',5,5a,5b,6,7,7a,8a,9,9a,9b,9c,9d-octaadecahydrospiro(cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthren-8,5'-furan)-2',3-dione, 6beta,7beta:15beta,16beta -Dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone, Dihydrospirorenone, Spiro[8H-cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthrene-8,2'(5'H)-furan]-3,5'(4H)-dione, 1,1a,3',4',5,5a,5b,6,7,7a,8a,9,9a,9b,9c,9d-hexadecahydro-5a,7a-dimethyl-, (1aR,5aR,5bS,7aS,8S,8aS,9a R,9bS,9cR,9dR)-

Id:68873

Description:nan